Concerns over the Accessibility of Nicotine E-cigarettes in Queensland, Australia

Aug.18.2022
Concerns over the Accessibility of Nicotine E-cigarettes in Queensland, Australia
Ease of purchasing nicotine e-cigarettes in Queensland, Australia raises concerns over enforcement of regulations. Doctors warn against targeting non-smokers, especially youths.

The accessibility of nicotine e-cigarettes in Queensland, Australia has become a matter of concern. According to the American Medical Association, since October, Australians must have a prescription to legally obtain e-cigarettes containing nicotine, but the regulatory measures have not been effectively enforced. Doctors have expressed that these products are "clearly" targeted towards non-smokers, specifically youth and young adults.


According to a doctor, electronic cigarette products are "clearly" targeted towards non-smokers (image source: AP). Maria Bolton, the president of the Queensland Medical Association, stated that tobacco companies promote e-cigarettes as a smoking cessation aid, but currently liquid nicotine e-cigarette products are not approved for use in Australia.


According to the American Medical Association, despite nearly 84% of individuals never having smoked, over 20% of 18-24 year olds have used e-cigarettes in the 2020-21 year. State government data reveals that approximately 16% of Queensland high school students have reported using e-cigarettes.


Dr. Boulton stated that many teenagers believe that the dangers of vaping are lower than smoking, but it can lead to addiction and inhaling heated gases has been proven to be harmful to the lungs.


Queensland's failure to enforce these laws means that these products are easily accessible, including some that are falsely labeled as "nicotine-free" and others that contain 50 times more nicotine than cigarettes.


A young woman living in the Brisbane city center reported that local suppliers have nicotine e-cigarettes available at their counters, and they will even offer discounts if you pay in cash. When she attempted to purchase non-nicotine e-cigarettes, she was told that the nicotine products were better. Another Brisbane resident suggested asking about available flavors and mentioning that you will pay in cash in order to purchase nicotine e-cigarettes. A woman from the Sunshine Coast claimed that "gift shops" sell e-cigarettes and nicotine versions are typically easy to obtain. However, she also noted that some legitimate vendors, usually tobacco retailers, do not easily sell nicotine products and require identification.


The American Medical Association has written to the Health Minister and Attorney General, urging them to "urgently correct these mistakes before the children of Queensland become the next generation of smokers and suffer the associated catastrophic health consequences".


Dr. Boulton is calling on the government to take action on a series of proposed legal reforms in its tobacco law reform discussion paper, including banning smoking in outdoor markets and school parking lots, disallowing children from smoking in bars and clubs, and requiring tobacco retailers to obtain licenses.


Queensland Health Minister Yvette D'Ath has announced that measures to crack down on the illegal tobacco industry are being considered as part of Queensland's smoking law reforms. In a statement released in May, she expressed the goal of granting authorities additional enforcement powers to combat the illegal tobacco trade.


Statement


This article is compiled from third-party information and is intended for industry professionals for exchange and learning purposes.


This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is solely for industry communication and research purposes.


Due to limitations in translation abilities, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS completely aligns its statements and positions with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria Smokeable Profit Rises 2.4% as Marlboro Share Falls and U.S. Discounts Gain
Altria’s second-quarter results show a U.S. nicotine market splitting across price, product and regulation. Smokeable profit rose 2.4% as Marlboro pricing offset lower volumes, while discount brand Basic gained share among value-conscious smokers. In oral nicotine, on! PLUS expanded distribution but faced intensifying competition from ZYN and Velo. NJOY remained off the market as patent and regulatory hurdles delayed its return. The broader lesson: U.S. growth increasingly depends on price-tier strategy, retail execution, authorisation and enforcement readiness across the industry.
Special Report
Jul.31
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
Ohio Supreme Court Weighs Whether State Consumer Law Can Restrict Flavored Vape Sales
Ohio Supreme Court Weighs Whether State Consumer Law Can Restrict Flavored Vape Sales
The Ohio Supreme Court is hearing a case involving flavored vape sales and whether state authorities can use consumer protection laws to take action against retailers selling unauthorized vape products. Ohio officials argue that selling unauthorized flavored vapes may constitute consumer deception, while retailers argue that tobacco product regulation falls under federal Food and Drug Administration (FDA) authority and that states cannot impose additional restrictions through consumer laws. The case could affect the scope of state-level vape regulation across the United States.
Aug.06
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
WIRED Investigation: Chinese-Made Vapes Turn to 6-Methyl-Nicotine and Other Analogs, Challenging U.S. Regulation
U.S. technology and investigative publication WIRED has examined how nicotine analogs are emerging as a new challenge for the country’s vape regulatory framework. The article argues that after the U.S. expanded federal oversight of nicotine products in 2022, some manufacturers began using nicotine-like compounds such as 6-methyl-nicotine that may fall outside existing definitions. Researchers cited by WIRED said some nicotine analogs could be more potent than traditional nicotine, although human health impacts remain unclear. U.S. policymakers are considering broader definitions of nicotine to bring these compounds under federal oversight.
Jul.27